Stibine

CAS RN:7803-52-3

Treatment Overview

0.4.3 INHALATION EXPOSURE
  • A) Human exposures to stibine gas are uncommon. More human cases need to be described before an accurate picture of the intoxication can be drawn. Treatment is primarily supportive as necessary. Insure adequate hydration by starting intravenous fluids. Severe hemolytic anemia can occur. Maintaining adequate urine output may prevent renal damage by disposition of hemoglobin and hemoglobin breakdown products. Exchange transfusion should be considered.
  • B) INHALATION: Move patient to fresh air. Monitor for respiratory distress. If cough or difficulty breathing develops, evaluate for respiratory tract irritation, bronchitis, or pneumonitis. Administer oxygen and assist ventilation as required. Treat bronchospasm with an inhaled beta2-adrenergic agonist. Consider systemic corticosteroids in patients with significant bronchospasm.
  • C) If major hemolysis has occurred, exchange transfusion may be performed to remove plasma hemoglobin in conjunction with hemodialysis to preserve renal function.
  • D) ECG - An ECG should be performed because cardiac conduction abnormalities may occur.
0.4.4 EYE EXPOSURE
  • A) DECONTAMINATION: Remove contact lenses and irrigate exposed eyes with copious amounts of room temperature 0.9% saline or water for at least 15 minutes. If irritation, pain, swelling, lacrimation, or photophobia persist after 15 minutes of irrigation, the patient should be seen in a healthcare facility.
0.4.5 DERMAL EXPOSURE
  • A) OVERVIEW
    • 1) DECONTAMINATION: Remove contaminated clothing and jewelry and place them in plastic bags. Wash exposed areas with soap and water for 10 to 15 minutes with gentle sponging to avoid skin breakdown. A physician may need to examine the area if irritation or pain persists (Burgess et al, 1999).
Find more information on this substance at: Hazardous Substances Data Bank , TOXNET , PubMed